Xynomic Pharmaceuticals Holdings, Inc. announced that one incumbent director of Bison, Peixin Xu, resigned from board of directors upon closing of the Business Combination. Board of directors currently consists of four existing Bison directors, Messrs. Richard Wu, Thomas Folinsbee, Charles Prizzi and James Jiayuan Tong to its board of directors, and three newly appointed directors Yinglin Mark Xu, Tingzhi Qian and Adam Inglis.